Applied Biosystems' ViroSeq gets thumbs-up in Argentina:
This article was originally published in Clinica
Argentina has become the first country to approve Applied Biosystems' HIV-1 genotyping kit for clinical use. The ViroSeq version 2 kit is used to detect cases of drug-resistant HIV-1 mutations as part of an HIV therapy management system. It will be distributed in Argentina by Buenos Aires-based BioSystems SA. Foster City, California-based Applied Biosystems submitted the test to the FDA for US marketing clearance earlier this year.